1. Home
  2. MRNA vs FHN Comparison

MRNA vs FHN Comparison

Compare MRNA & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • FHN
  • Stock Information
  • Founded
  • MRNA 2010
  • FHN 1864
  • Country
  • MRNA United States
  • FHN United States
  • Employees
  • MRNA N/A
  • FHN N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • FHN Major Banks
  • Sector
  • MRNA Health Care
  • FHN Finance
  • Exchange
  • MRNA Nasdaq
  • FHN Nasdaq
  • Market Cap
  • MRNA 9.2B
  • FHN 11.0B
  • IPO Year
  • MRNA 2018
  • FHN N/A
  • Fundamental
  • Price
  • MRNA $24.45
  • FHN $21.53
  • Analyst Decision
  • MRNA Hold
  • FHN Buy
  • Analyst Count
  • MRNA 15
  • FHN 20
  • Target Price
  • MRNA $36.69
  • FHN $24.10
  • AVG Volume (30 Days)
  • MRNA 11.9M
  • FHN 15.6M
  • Earning Date
  • MRNA 11-06-2025
  • FHN 10-15-2025
  • Dividend Yield
  • MRNA N/A
  • FHN 2.79%
  • EPS Growth
  • MRNA N/A
  • FHN 19.36
  • EPS
  • MRNA N/A
  • FHN 1.65
  • Revenue
  • MRNA $2,232,000,000.00
  • FHN $3,184,000,000.00
  • Revenue This Year
  • MRNA N/A
  • FHN $12.70
  • Revenue Next Year
  • MRNA $10.38
  • FHN $2.54
  • P/E Ratio
  • MRNA N/A
  • FHN $13.01
  • Revenue Growth
  • MRNA N/A
  • FHN 3.75
  • 52 Week Low
  • MRNA $23.04
  • FHN $15.19
  • 52 Week High
  • MRNA $56.70
  • FHN $23.70
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 43.32
  • FHN 49.88
  • Support Level
  • MRNA $23.48
  • FHN $20.95
  • Resistance Level
  • MRNA $25.56
  • FHN $21.70
  • Average True Range (ATR)
  • MRNA 1.46
  • FHN 0.47
  • MACD
  • MRNA -0.32
  • FHN 0.11
  • Stochastic Oscillator
  • MRNA 15.89
  • FHN 83.00

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.

Share on Social Networks: